Investment
Features
FeesSafety
Academy
More
Pluang+

Compare IDEXX Laboratories, Inc. (IDXX) vs Carparts.Com Inc (PRTS) Price & Performance

IDEXX Laboratories, Inc.Trade
Carparts.Com IncTrade

Price performance (Past 24H)

Key statistics

IDEXX Laboratories, Inc. vs Carparts.Com Inc — how do they compare? IDEXX Laboratories, Inc. trades at $571.77 (market cap $46.22B), while Carparts.Com Inc trades at $6.35 (market cap $51.67M). The key difference: IDEXX Laboratories, Inc. is far larger — about 894.5× Carparts.Com Inc's market cap, and Carparts.Com Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.

IDXXPRTS
Market Cap
$46.22B$51.67M
Sector
HealthConsumer Cyclical
52-Week High
$766.68$11.40
52-Week Low
$526.44$3.88
Enterprise Value
$47.12B$66.64M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

IDEXX Laboratories, Inc.

IDEXX Laboratories (IDXX) trades at $595.76, up 1.55% on the day, with a bullish technical signal and strong fundamental performance. Recent Q2 2026 earnings beat expectations with EPS of $4.27 versus $3.94 expected, driven by 9% organic revenue growth. The company raised full-year EPS guidance to $14.69–14.94, reflecting robust demand in companion animal diagnostics. Valuation ratios remain elevated with a P/E of 41.23, supported by high profitability margins including a net income margin of 25.03% and ROE of 74.21%.

Outlook is positive given consistent earnings beats, international expansion, and product innovation, but risks include premium valuation sensitivity and competitive pressures. The consensus price target of $683.33 implies 14.7% upside, with 57% of analysts rating it Buy. Investors should weigh growth durability against high multiples.

Carparts.Com Inc

CarParts.com (PRTS) trades at $6.32, down 6.37% today, with a bullish technical signal despite negative profitability metrics. The company has beaten earnings expectations for three consecutive quarters, though revenue has declined from $676M in 2023 to $548M in 2025. Recent developments include a 10:1 reverse stock split completed in May 2026 and a new $25M credit facility, while analyst consensus remains positive with 60% buy ratings.

The outlook is mixed: technical indicators and analyst sentiment suggest potential upside, but fundamental challenges persist with negative net income margins and cash flow concerns. Key risks include ongoing operational losses and competitive pressures in the auto parts e-commerce space, requiring careful monitoring of the company's turnaround execution.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About IDEXX Laboratories, Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.

Read more on IDXX

About Carparts.Com Inc

CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.

Read more on PRTS